Gene signature predicts risk of metastasis in localised prostate cancer

META-16 might allow for more targeted treatment for patients at risk of cancer progression, while sparing men at low risk unnecessary treatment.
META-16 might allow for more targeted treatment for patients at risk of cancer progression, while sparing men at low risk unnecessary treatment.